Type 3 Choroidal Neovascularization
1 clinical trials · Condition
◉ Watch Type 3 Choroidal Neovascularization
| Record | Firm | Date |
|---|---|---|
| Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3) (NCT02320474) | Poitiers University Hospital | 2014-11-25 |
Track Type 3 Choroidal Neovascularization automatically
Every clearance here is in the API, with alerts when new ones post.